Medtronic plc
MDT
Rankning i aktier
#184
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Aktiekurs
$94.59
Senast synkroniserad: 2026-10-20
Marknadsvärde
$120.99B
Förändring (1 dag)
1.76%
Förändring (1 år)
-1.30%
Land
IE
Handel Medtronic plc (MDT)
Kategori
Healthcare
P/E-tal för Medtronic plc (MDT)
P/E-tal per May 2026 TTM: 21.39
Enligt Medtronic plc senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 21.39. I slutet av 2024 hade företaget ett P/E-tal på 28.98.
Historik för P/E-tal för Medtronic plc från 2000 till 2026
P/E-tal vid slutet av varje år
| År | P/E-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 21.39 | -8.48% |
| 2025 | 23.37 | -19.35% |
| 2024 | 28.98 | -9.95% |
| 2023 | 32.18 | 15.76% |
| 2022 | 27.80 | -43.06% |
| 2021 | 48.83 | 75.64% |
| 2020 | 27.80 | 9.46% |
| 2019 | 25.40 | -28.52% |
| 2018 | 35.53 | 24.91% |
| 2017 | 28.44 | -9.80% |
| 2016 | 31.53 | -0.78% |
| 2015 | 31.78 | 65.27% |
| 2014 | 19.23 | 40.13% |
| 2013 | 13.72 | 23.30% |
| 2012 | 11.13 | -23.39% |
| 2011 | 14.53 | -6.85% |
| 2010 | 15.60 | -5.77% |
| 2009 | 16.55 | -32.91% |
| 2008 | 24.67 | 13.60% |
| 2007 | 21.72 | -8.07% |
| 2006 | 23.62 | -33.21% |
| 2005 | 35.37 | 13.16% |
| 2004 | 31.26 | -13.97% |
| 2003 | 36.33 | -33.97% |
| 2002 | 55.03 | 7.28% |
| 2001 | 51.29 | -9.73% |
| 2000 | 56.83 | 0.00% |
P/E-tal för liknande företag eller konkurrenter
| Företag | P/E-tal | Skillnad i P/E-tal | Land |
|---|---|---|---|
| 33.11 | 54.80% |
US
|
|
| 28.94 | 35.33% |
US
|
|
| 17.34 | -18.93% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 132.30% |
US
|
Hur man läser ett P/E-tal
P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.
Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.
Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.